Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ellem Industria Farmaceutica was a prominent Italian pharmaceutical company based in Milan that specialized in respiratory, anti-infective, and dermatological therapies. The company played a crucial role in the Italian healthcare market, particularly through its strategic partnership and eventual integration with Glaxo (now GlaxoSmithKline). It was responsible for the commercialization of major respiratory brands such as Flixotide and Ventolin in Italy. Following its acquisition by Glaxo in 1992, Ellem's operations were fully absorbed into the parent company's Italian infrastructure, though its legacy products remain central to the GSK portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ellem Industria Farmaceutica.